MindWalk Holdings Corp. Company Profile
NASDAQ: HYFTHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.51 +5.59%
MindWalk at a glance
MindWalk Holdings Corp. (NASDAQ: HYFT) is a Biotechnology company in the Healthcare sector headquartered in Austin, TX. MindWalk is led by Dr. Jennifer Lynne Bath Ph.D. and employs about 74 people. At a market capitalization of $67.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001715925, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does MindWalk do?
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Business description based on the company's public filings.
Company information
- Legal name
- MindWalk Holdings Corp.
- Ticker
- NASDAQ: HYFT
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Jennifer Lynne Bath Ph.D.
- Employees
- 74
- Headquarters
- Industrious 823 Congress Ave, Austin, TX, United States
- Phone
- 800 620 4187
- Website
- mindwalkai.com
- Market cap
- $67.37M
- SEC CIK
- 0001715925
Companies similar to MindWalk
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XBITXBiotech Inc. | 2.20 | +0.46% | $67.07M | vs HYFT |
| HRTXHeron Therapeutics Inc. | 0.3582 | -6.79% | $68.01M | vs HYFT |
| SPROSpero Therapeutics Inc. | 1.14 | -2.56% | $66.39M | vs HYFT |
| RNTXRein Therapeutics Inc. | 0.7693 | -2.46% | $66.37M | vs HYFT |
| CSBRChampions Oncology Inc. | 4.98 | +2.05% | $69.31M | vs HYFT |
| TENXTenax Therapeutics Inc. | 1.86 | -2.62% | $69.61M | vs HYFT |
| FBIOFortress Biotech Inc. | 2.09 | +2.45% | $69.70M | vs HYFT |
| GANXGain Therapeutics Inc. | 1.62 | -3.29% | $70.48M | vs HYFT |